BOULDER, CO – Auddia Inc. (NASDAQ: AUUD) today spotlighted Influence Healthcare, a healthtech company leveraging artificial intelligence and vertical integration to empower surgeons to lead the adoption of value-based care (VBC) in high-spend specialties such as spine and total joint surgery. The announcement comes as Auddia prepares to file its Form S-4 with the Securities and Exchange Commission, a key step in its pending merger with Thramann Holdings, LLC.
Influence Healthcare is built on the premise that physicians should control the clinical pathway and participate in the value they create. The company organizes surgeons into vertically integrated Value Based Enterprises (VBEs) that contract for bundled case-rate payments, supported by advanced AI workflows that automate documentation, coding, episode validation, care-pathway coordination, staffing, supply chain, and logistics. This model aims to reduce administrative burden and allow surgeons to focus on patient care.
Jeff Thramann, M.D., CEO of Auddia and founder of Influence Healthcare, stated: “Healthcare is about a physician and patient entering into a relationship to optimize delivery of the highest quality care. Only the physician has the knowledge, relationship with the patient, and clinical authority to make the many real-time decisions required to deliver the highest quality care at the lowest possible price. Influence Healthcare is aimed at leveraging AI to minimize administrative noise so that physicians and all the other healthcare professionals with hands on patients are empowered to deliver the highest value care.”
The Influence Healthcare model is positioned as a structural alternative to hospital employment and private-equity rollups, both of which often reduce physician autonomy. In contrast, Influence Healthcare’s surgeon-led enterprises retain governance authority, flow episode-based economics to clinicians, align facilities through partnerships, and use AI to reduce overhead. “We are creating a structure where surgeons control the clinical pathway, participate in the value they create, and are supported by AI systems that eliminate the administrative drag that is making independent practice difficult,” Dr. Thramann added.
Post-merger, Influence Healthcare will leverage shared AI services from McCarthy Finney, the combined entity, to deploy agentic-AI workflows that automate clinical documentation, coding, billing preparation, episode-of-care validation, prior-authorization workflows, care-pathway adherence monitoring, and communication across the episode. These workflows are designed to replace multiple full-time administrative staff per surgeon, reducing burnout and inefficiency.
Influence Healthcare’s VBEs integrate surgeon leadership, facility partners (ASCs, hospitals, imaging centers), post-acute providers, AI-enabled care coordination, and episode-based financial alignment. This creates a cohesive end-to-end specialty care model without requiring surgeons to sell their practices or surrender governance. The model is designed to deliver lower total cost of care, improved outcomes, reduced administrative overhead, predictable economics for payers and employers, and restored autonomy for surgeons.
The company’s initial focus is on spine and total joint surgery, with plans to expand to additional specialties and markets through physician-led VBEs. For more information, visit www.influencehealthcare.com.
The merger between Auddia and Thramann Holdings, expected to close pending regulatory and stockholder approvals, will result in the combined company being named McCarthy Finney and trading under the ticker MCFN. McCarthy Finney will operate as an AI holding company with four portfolio companies: LT350, Influence Healthcare, Voyex, and Auddia. Auddia anticipates filing the S-4 later this week, which will contain important information about the transaction. Investors can find more details in Auddia’s filings with the SEC, available at www.sec.gov.
